Stocks · US
MEDP
XNAS
Medpace Holdings, Inc. Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E35.24x
P/B39.92x
P/S6.22x
EPS$17.61
ROE113.29%
ROA23.89%
Dividend yield0.00%
EV/EBITDA27.51x
Debt/Equity0.00
Free cash flow$707M
Returns and 52-week range
1W-3.09%
1M+1.96%
3M+13.33%
6M+18.56%
1Y+13.22%
YTD+5.58%
52W high$677.90
52W low$373.00
From 52W high-11.06%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. | $17.5B | 21.65 | 1.38 | -8.56% |
| Jazz Pharmaceuticals, Inc. | $15.3B | 16.29 | 3.19 | -6.25% |
| Revvity, Inc. | $17.6B | 73.92 | 2.43 | +17.72% |
| 템퍼스 AI | $15.2B | — | 34.09 | +11.39% |
| 비아트리스 | $20.2B | — | 1.42 | +3.91% |
| Solventum Corporation | $15.0B | 10.45 | 3.12 | -5.07% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.